https://www.avient.com/sites/default/files/2022-03/AVNT Mar 2022 Presentation.pdf
Microsoft PowerPoint - AVNT Mar 2022 Presentation
AVIENT CORPORATION
I N V E S T O R M E E T I N G S
(NYSE: AVNT)
M A R C H 2 0 2 2
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
30
Capex / Revenue
2022E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3
2
2
3
3
4
3
3
5
5
5
7
7 7
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
O U R VA LUATI O N V E R S U S P E E R S
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
5.4
8.5
10.1 10.0
15.7
15.0
14.2
12.7
10.2
25.0
19.7
17.7
13.2
12.3
10.0 9.9
8.9 8.5 8.3
6.6
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
6
)
A
vi
e
n
t
(2
0
2
1
)
A
vi
e
n
t
(T
o
d
a
y)
R
P
M
K
W
R
P
P
G
A
V
Y
F
U
L
A
L
B
E
C
L
H
X
L
A
S
H
F
M
C
B
N
R
E
M
N
U
N
V
R
C
E
S
C
L
H
U
N
Historic Multiple
S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
Avient corporation first quarter 2023 results
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
J A N U A R Y 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
GUIDANCE
$800
$754
Guidance Actual
$128
$123
Guidance Actual
Sales Adjusted EBITDA
(in millions)
$0.56 $0.57
Guidance Actual
Adjusted EPS
(in millions)
13
• Demand impacted by destocking
and cautious customer sentiment
• Positive net price benefit:
o CAI - Pricing flat and raw
material deflation
o SEM - Pricing flat with
unfavorable mix related to
healthcare, more than offset
with raw material deflation
• Cost reductions driven by Clariant
synergies and reduced
administrative costs
Q3 EBITDA BRIDGE
($ millions)
CAI:
Price / Mix -)
Deflation 22)
SEM:
Price / Mix (6)
Deflation 13)
Net Price Benefit 29)
Cost Reductions 13)
Wage Inflation (8)
FX 1)
Q3 2023 Actual $ 123)
Adjusted
EBITDA
Q3 2022 Pro Forma $ 137)
Demand (49)
14
2 0 2 3 G U I D A N C E
Q4 2023 GUIDANCE VS.
Avient 2011, 2018 and 2021 multiples reflect trailing 12 months EBITDA at December 31.
28
EV / 2023E EBITDA
6.5
8.5
11.0 10.8
16.1 15.5
14.1 14.0
10.3
21.0
19.0
14.3
12.1 11.8 11.7 11.5
9.7
20
11
20
18
20
21
20
23
R
P
M
A
V
Y
P
P
G
K
W
R
FU
L
E
C
L
H
X
L
S
C
L
C
E
FM
C
A
S
H
H
U
N
E
M
N
Avient Historic Multiple
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
A P P E N D I X
30
Performance
Additives
16%
Pigments
12%
TiO2
10%
Dyestuffs
2%
Polyethylene
11%
Nylon
6%
Polypropylene
5%
Styrenic Block
Copolymer
5%
Other Raw
Materials
33%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
2022 pro forma results for the acquisition of Avient Protective Materials
RA W MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
40%
EMEA
37%
Asia
18%
Latin America
5%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
20%
Packaging
24%
Industrial
15%
Building and
Construction
10%
Telecommunications
4%
Energy
4%
Defense
6%
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
Transportation
9%
Healthcare
8%
32
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N
US & Canada
34%
EMEA
38%
Asia
20%
Latin America
8%
END MARKET REGION
33
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
8%
Building &
Construction
11%
Telecommunications
1% Energy
2%
COLOR, ADDITIVES & INKS
2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
34
Packaging
5%
Consumer
19%
Healthcare
8%Industrial
16%
Transportation
10%
Telecommunications
10%
Energy
9% Defense
15%
Building &
Construction
8%
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
Packaging
32%
Consumer
27%
Healthcare
8%
Industrial
14%
Building &
Construction
5%
Telecommunications
3%
Energy
1% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S
Packaging
27%
Consumer
14%
Healthcare
5%
Industrial
17%
Building &
Construction
10%
Energy
5%
Defense
8%
EMEA
(37% of sales)Transportation
11%
Packaging
13%
Consumer
24%
Healthcare
12%
Industrial
15%
Building &
Construction
13%
Energy
5%
Defense
5%
US &
Canada
(40% of sales)
Transportation
7%
Packaging
56%
Consumer
23%
Healthcare
4%
Industrial
7%
Building &
Construction
4%
Telecommunications
1%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
3%
Telecommunications
6%
35
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2021-12/avient-sarl-hungary-branch-register-extract-2021-12-07.pdf
Name of the company
2/2.
Abbreviated name of the company
3/2.
Tax number: 26500971-2-08.
https://www.avient.com/sites/default/files/resources/0514_02%2520PDI%2520ISO17025%2520Chemical_Extension%2520Cert2019.pdf
No. 0514.02) Revised 10/08/2019 Page 1 of 2
SCOPE OF ACCREDITATION TO ISO/IEC 17025:2005
POLYMER DIAGNOSTICS INC.
33587 Walker Road
Avon Lake, OH 44012
Ana De La Ree Phone: 440-930-3271
CHEMICAL
Valid To: December 31, 2019 Certificate Number: 0514.02
In recognition of the successful completion of the A2LA evaluation process, accreditation is granted to this
laboratory to perform the following rubber and plastics tests:
Test Description:
Test Method or Standard:
Analysis of Volatile Contaminants from Polymers
(Chromatography)
VDA 277
FTIR (Fourier Transform Infrared) Spectroscopy
ASTM E1252 (Except 7.6, 11.2, and 11.4)
Flammability
Horizontal Burn of Self-Supporting Plastics ASTM D635; UL 94; IEC 60695-11-10
Horizontal Burn of Materials Used in Occupant
Compartments of Motor Vehicles
ASTM D5132; FMVSS 302 (49 CFR 571.302)
Vertical Burn, 20 mm ASTM D3801; UL 94; IEC 60695-11-10
Vertical Burn, 125 mm ASTM D5048; UL 94; IEC 60695-11-20
Oxygen Index ASTM D2863
FT1 Flame Test UL1581, Clause 1060;
UL2556/CSA C22.2 No 2556, Clause 9.3
Cable Flame Test UL1581, Clause 1061
VW1 Flame Test UL1581, Clause 1080;
UL2556/CSA C22.2 No 2556, Clause 9.4
FT2/FH Flame Test UL1581, Clause 1100;
UL2556/CSA C22.2 No 2556, Clause 9.1
FV-1 Flame Test UL1581, Clause 1060;
UL2556/CSA C22.2 No 2556, Clause 9.5
Thin Material Burning Test UL-94
Glow Wire Test
IEC 60695 2-10, 2-11, 2-12, 2-13
RVCM in PVC
ASTM D4443
(A2LA Cert.
No. 0514.02) Revised 10/08/2019 Page 2 of 2
Test Description:
Test Method or Standard:
Thermal Analysis
DSC (Differential Scanning Calorimetry) ASTM D3418, E794, E1356
TGA (Thermogravimetric Analysis)
ASTM E1131
Karl Fischer Moisture Content
ASTM D6869
Phthalate Determination by CPSIA CPSC-CH-C1001-09.3
1 The Consumer Product Safety Improvement Act (CPSIA) requires that every children's product subject to a federal
consumer product safety requirement be tested by a Consumer Product Safety Commission (CPSC) accepted laboratory
for compliance with the applicable federal children's product safety requirements.
https://www.avient.com/sites/default/files/2021-11/0514-02-dec2021.pdf
No. 0514.02) Revised 09/21/2021 Page 1 of 2
SCOPE OF ACCREDITATION TO ISO/IEC 17025:2017
POLYMER DIAGNOSTICS INC.
33587 Walker Road
Avon Lake, OH 44012
Ana De La Ree Phone: 440-930-3271
CHEMICAL
Valid To: December 31, 2021 Certificate Number: 0514.02
In recognition of the successful completion of the A2LA evaluation process, accreditation is granted to this
laboratory to perform the following rubber and plastics tests:
Test Description:
Test Method or Standard:
Analysis of Volatile Contaminants from Polymers
(Chromatography)
VDA 277
FTIR (Fourier Transform Infrared) Spectroscopy
ASTM E1252 (Except 7.6, 11.2, and 11.4)
Flammability
Horizontal Burn of Self-Supporting Plastics ASTM D635; UL 94; IEC 60695-11-10
Horizontal Burn of Materials Used in Occupant
Compartments of Motor Vehicles
ASTM D5132; FMVSS 302 (49 CFR 571.302);
ISO 3785
Vertical Burn, 20 mm ASTM D3801; UL 94; IEC 60695-11-10
Vertical Burn, 125 mm ASTM D5048; UL 94; IEC 60695-11-20
Oxygen Index ASTM D2863
FT1 Flame Test UL1581, Clause 1060;
UL2556/CSA C22.2 No 2556, Clause 9.3
Cable Flame Test UL1581, Clause 1061
VW1 Flame Test UL1581, Clause 1080;
UL2556/CSA C22.2 No 2556, Clause 9.4
FT2/FH Flame Test UL1581, Clause 1100;
UL2556/CSA C22.2 No 2556, Clause 9.1
FV-1 Flame Test UL1581, Clause 1060;
UL2556/CSA C22.2 No 2556, Clause 9.5
Thin Material Burning Test UL-94
Glow Wire Test
IEC 60695 2-10, 2-11, 2-12, 2-13
RVCM in PVC
ASTM D4443
(A2LA Cert.
No. 0514.02) Revised 09/21/2021 Page 2 of 2
Test Description:
Test Method or Standard:
Thermal Analysis
DSC (Differential Scanning Calorimetry) ASTM D3418, E794, E1356
TGA (Thermogravimetric Analysis)
ASTM E1131
Karl Fischer Moisture Content
ASTM D6869
Phthalate Determination by CPSIA CPSC-CH-C1001-09.3, CPSC-CH-C1001-09.4
1 The Consumer Product Safety Improvement Act (CPSIA) requires that every children's product subject to a
federal consumer product safety requirement be tested by a Consumer Product Safety Commission (CPSC)
accepted laboratory for compliance with the applicable federal children's product safety
requirements.
https://www.avient.com/sites/default/files/2022-01/Avient Sarl%2C Germany Branch Extract Dec 23 2021.pdf
Handelsregister B des Amtsgerichts Mannheim Nummer der Firma:
Seite 1 von 2
HRB 731450
Nummer
der
Eintragung
a) Firma
b) Sitz, Niederlassung, inländische
Geschäftsanschrift, empfangsberechtigte
Person, Zweigniederlassungen
c) Gegenstand des Unternehmens
Grund- oder
Stammkapital
a) Allgemeine Vertretungsregelung
b) Vorstand, Leitungsorgan, geschäftsführende
Direktoren, persönlich haftende Gesellschafter,
Geschäftsführer, Vertretungsberechtigte und
besondere Vertretungsbefugnis
Prokura a) Rechtsform, Beginn, Satzung oder Gesellschaftsvertrag
b) Sonstige Rechtsverhältnisse
a) Tag der Eintragung
b) Bemerkungen
1 2 3 4 5 6 7
1 a)
PolyOne S.à r.l., Germany Branch
b)
Gaggenau
Geschäftsanschrift:
Adolf-Dambach-Straße 2, 76571 Gaggenau
Zweigniederlassung der "PolyOne S.à r.l."
mit Sitz in Pommerloch / Luxemburg
(Registre de commerce et des sociétés
B226205)
c)
Den Vertrieb und den Großhandel von
Fertigerzeugnissen, die unter anderem aus
ein- und mehrschichtigen
thermoplastischen Platten,
Polymermischungen und Farbkonzentraten
sowie klaren thermogeformten
Kunststoffbehältern bestehen, wobei die
Tätigkeiten für die das Gesetz besondere
Qualifikationen oder Erlaubnisse
vorschreibt, die von der
Zweigniederlassung nicht erfüllt oder
gehalten werden, ausdrücklich
ausgeschlossen sind.
12.000,00
EUR
a)
Jeder Geschäftsführer vertritt einzeln.
a)
10.09.2018
Kretzler
2 b)
Bestellt als
Geschäftsführer:
Fielding, Gary J., Chesire / Vereinigtes
Königreich, *20.09.1963
Bestellt als
Geschäftsführer:
Potoczny, Zaneta Gabriela, Mersch / Luxemburg,
*17.10.1974
Ausgeschieden als
Geschäftsführer:
Machin, Geneviéve Elizabeth, Luxemburg /
Luxemburg, *31.03.1972
a)
17.03.2020
Knauf
Abruf vom 27.12.2021 17:13
Handelsregister B des Amtsgerichts Mannheim Nummer der Firma:
Seite 2 von 2
HRB 731450
Nummer
der
Eintragung
a) Firma
b) Sitz, Niederlassung, inländische
Geschäftsanschrift, empfangsberechtigte
Person, Zweigniederlassungen
c) Gegenstand des Unternehmens
Grund- oder
Stammkapital
a) Allgemeine Vertretungsregelung
b) Vorstand, Leitungsorgan, geschäftsführende
Direktoren, persönlich haftende Gesellschafter,
Geschäftsführer, Vertretungsberechtigte und
besondere Vertretungsbefugnis
Prokura a) Rechtsform, Beginn, Satzung oder Gesellschaftsvertrag
b) Sonstige Rechtsverhältnisse
a) Tag der Eintragung
b) Bemerkungen
1 2 3 4 5 6 7
3 a)
Firma geändert; nun:
Avient S.à r.l., Germany Branch
b)
Daten der Hauptniederlassung geändert;
nun:
Zweigniederlassung der "Avient S.à r.l." mit
Sitz in Pommerloch / Luxemburg (Registre
de commerce et des sociétés B226205)
b)
Ausgeschieden als
Geschäftsführer:
Fielding, Gary J., Chesire / Vereinigtes
Königreich, *20.09.1963
Bestellt als
Geschäftsführer:
Merklein, Norbert, Kronberg im Taunus,
*03.05.1964
a)
Der geänderte Gesellschaftsvertrag der Hauptniederlassung
wurde zum Handelsregister eingereicht.
https://www.avient.com/sites/default/files/2022-02/AVNT Q4 2021 Earnings Presentation_0.pdf
Microsoft PowerPoint - AVNT Q4 2021 Earnings Presentation (v17) - W PEERS x ESI
AVIENT CORPORATION
F O U R T H Q U A R T E R 2 0 2 1 R E S U L T S
A N D 2 0 2 2 F I N A N C I A L G U I D A N C E
(NYSE: AVNT)
F E B R U A R Y 8 , 2 0 2 2
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
26
Capex / Revenue
2022E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2
3
2
2
3
3
4
3
3
5
5
5
7
7 7
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
O U R VA LUATI O N V E R S U S P E E R S
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
5.4
8.5
10.1 10.0
15.7
15.0
14.2
12.7
10.2
25.0
19.7
17.7
13.2
12.3
10.0 9.9
8.9 8.5 8.3
6.6
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
6
)
A
vi
e
n
t
(2
0
2
1
)
A
vi
e
n
t
(T
o
d
a
y)
R
P
M
K
W
R
P
P
G
A
V
Y
F
U
L
A
L
B
E
C
L
H
X
L
A
S
H
F
M
C
B
N
R
E
M
N
U
N
V
R
C
E
S
C
L
H
U
N
Historic Multiple
S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/sites/default/files/2020-12/artisan-thermoplastics-nylon-processing-guide.pdf
Many different types of gates can be used such as pin, fan, tunnel,
tab and edge gates
2.
Full-round runners or modified trapezoid runners are the best designs
2.
Place vents at the end of fill and anywhere potential knit/weld lines will occur
2.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Page 2
Use of Non GAAP Measures
• This presentation includes the use of both GAAP (generally accepted accounting
principles) and non‐GAAP financial measures.
EPS: $2.50
Assumptions
• High single digit organic
revenue CAGR
• Operating margins in mid range
of 2015 targets
• No global recession• No global recession
• No investment in incremental
PP&S capacity
• Completion of 2‐3 midsize
accretive acquisitions
• No divestitures
• Housing starts at 85% of 50 year
norm by 2015
R i f t bl b l 3X N t
2012
$ • Remain comfortably below 3X Net
Debt / EBITDA
Page 13
Rev: $3.0B
Adj.
EPS: $1.20
Proforma Debt Maturities & Liquidity Summary – 12/31/12
(Reflecting Financing & Spartech Acquisition)
• Total Debt at 12/31/12
h
$1,010
$297
$360 $300
$400
Debt Maturities
As of December 31, 2012
($ millions)
Less: Cash
Net Debt
213
$797
$50
$297
$100
$200
• Available Liquidity
Cash $213
$800 Debt Maturities
As of December 31, 2012
P f f 2/13 Fi i
$50
$0
2015 2017 2020
Interest Rates: 7.500% 5.000% 7.375%
Cash
ABL Availability
Total Liquidity
$213
271
$484
$600
$400
$600
Proforma for 2/13 Financing
($ millions)
Total Liquidity
• Net Debt / EBITDA = 2.0x*
$484
$50
$360
$0
$200
• Net Debt / EBITDA = 2.35x**
$50$0
2015 2020 2023
Page 14
Interest Rates: 7.500% 7.375% 5.250%
*Assumes $65 million of synergies related to Spartech acquistion
**Assumes no synergies related to Spartech acquistion
Use of Cash
Share DividendsOrganic G Acquisitions
• Repurchased 1 2
Repurchase
• Introduced a
Dividends
• Expanding our
Growth
T t th t d
Acquisitions
• Repurchased 1.2
million shares in
2012
• 20.0 million
shares are
il bl f
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
available for
repurchase under
the current
authorization
Q1 2013 (20%)
• Objective of
maintaining and
growing
Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
• Synergy opportunities
• Adjacent material solutions
Proforma Cash Balance = $213M
N t D bt / EBITDA* 2 0X
CAPEX
Net Debt / EBITDA* = 2.0X
*Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period
Page 15
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
Audit 2.
Committees: 1, 2
Gregory J.
Committees: 2, 3
Kerry J.